A revolutionary depression treatment now available at Medical University of South Carolina delivers relief in days rather than months, offering hope for patients with severe depression that has not responded to drugs or psychotherapy. Stanford Neuromodulation Therapy (SAINT) condenses transcranial magnetic stimulation into an accelerated five-day protocol, with results showing remission rates of 80% by day five.
How SAINT Works
Rather than delivering treatment over several weeks, the SAINT protocol involves 10 sessions per day over five days. Using functional MRI scans and machine learning analysis, physicians pinpoint the exact area of the dorsolateral prefrontal cortex that requires stimulation for each patient, personalizing treatment with precision targeting. With treatments of 10 minutes each hour followed by 50 minutes of rest, patients feel a tapping sensation on their heads. The average time to remission is only 2.6 days, with an overall 80% to 90% remission rate for treatment-resistant depression.
Context on Traditional TMS
MUSC pioneered clinical transcranial magnetic stimulation in the early 1990s. Typically, TMS treatments are administered in 20-minute sessions over several weeks for a total of 30 to 36 treatments. Real-world data suggests that TMS leads to complete remission of depression in 62% of patients, with an 83% response rate. People tend to start feeling better at about week four, although many feel better much sooner.
Broader Significance
One challenge is limited insurance coverage, currently available primarily through Medicare and select insurers. Side effects include minor discomfort at the treatment site and muscle twitching. Major depressive disorder remains one of the few serious medical conditions not treated with the urgency of illnesses such as cancer or heart disease, yet 25% of people with major depression will try to commit suicide.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.musc.edu/content-hub/News/2026/04/14/tms-treatment